Update on the Development of DS-1062a, a Trop-2 Targeting DXd ADC

Time: 4:20 pm
day: Day Two

Details:

  • Evaluating the pre-clinical profile and mechanism of action of DS-1062a
  • Sharing the clinical development status of DS-1062a
  • Discussing future developments of DS-1062a

Speakers: